Free Trial

Genus (LON:GNS) Stock Crosses Below Two Hundred Day Moving Average - Here's Why

Genus logo with Medical background

Genus plc (LON:GNS - Get Free Report) shares crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 1,799.55 ($22.52) and traded as low as GBX 1,492 ($18.67). Genus shares last traded at GBX 1,532 ($19.17), with a volume of 57,657 shares trading hands.

Wall Street Analyst Weigh In

Separately, Shore Capital reiterated a "buy" rating on shares of Genus in a report on Wednesday, December 11th.

Check Out Our Latest Stock Report on GNS

Genus Stock Performance

The company has a market capitalization of £1.02 billion, a price-to-earnings ratio of 12,916.67, a price-to-earnings-growth ratio of 2.87 and a beta of 0.37. The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.54. The stock has a 50-day simple moving average of GBX 1,775.12 and a 200-day simple moving average of GBX 1,797.68.

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Featured Articles

→ Stunning Trump Exec Order Leaked (From Banyan Hill Publishing) (Ad)

Should you invest $1,000 in Genus right now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Unveils Game-Changing Tech, But Stock Dips
Rivian Stock Surge Analysis: Long-Term Potential or Short-Term Play?
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines